乳腺X线摄影与乳腺X线摄影联合全乳超声断层成像在致密乳腺患者中检出乳腺癌的比较
该回顾性多阅片者多病例研究纳入140例致密乳腺女性(36例癌症,104例无癌症),32名放射科医师独立评估FFDM及FFDM联合UST。FFDM联合UST较FFDM单独在癌症检出AUC(0.60 vs 0.54,P=0.03)及BI-RADS 4敏感度(37% vs 30%,P=0.03)上更优,BI-RADS 4特异度非劣(82% vs 88%,P=0.004),BI-RADS 3敏感度无差异(40% vs 33%,P=0.08),但BI-RADS 3特异度更优(75% vs 69%,P=0.04)。
要点
- 致密乳腺女性中,FFDM联合UST较FFDM单独提高癌症检出AUC(0.60 vs 0.54,P=0.03)。
- FFDM联合UST的BI-RADS 4敏感度更高(37% vs 30%,P=0.03),特异度非劣(82% vs 88%,P=0.004)。
- BI-RADS 3敏感度无差异(40% vs 33%,P=0.08),但特异度更优(75% vs 69%,P=0.04)。
核心结论
- 在致密乳腺女性中,FFDM联合UST较FFDM单独改善放射科医师的癌症检出。
研究设计与样本
- 回顾性多阅片者多病例研究,纳入140例致密乳腺女性(平均年龄56岁±10[SD]),来自10个中心2017年8月至2019年10月的前瞻性病例收集登记,32名符合乳腺摄影质量标准法案的放射科医师独立评估FFDM及FFDM联合UST。
诊断标准与关键数值
- FFDM联合UST vs FFDM单独:AUC 0.60(95%CI:0.51,0.69)vs 0.54(95%CI:0.45,0.64),P=0.03。
- FFDM联合UST vs FFDM单独:BI-RADS 4平均敏感度37%(428/1152)vs 30%(343/1152),P=0.03;平均特异度82%(2741/3328)vs 88%(2916/3328),P=0.004(非劣效界值-10%,单侧α=0.025)。
- FFDM联合UST vs FFDM单独:BI-RADS 3平均敏感度40%(461/1152)vs 33%(385/1152),P=0.08;平均特异度75%(2491/3328)vs 69%(2299/3328),P=0.04。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Women with dense breasts benefit from supplemental cancer screening with US, but US has low specificity.
PURPOSE: To evaluate the performance of breast US tomography (UST) combined with full-field digital mammography (FFDM) compared with FFDM alone for breast cancer screening in women with dense breasts.
MATERIALS AND METHODS: This retrospective multireader multicase study included women with dense breasts who underwent FFDM and UST at 10 centers between August 2017 and October 2019 as part of a prospective case collection registry. All patients in the registry with cancer were included; patients with benign biopsy or negative follow-up imaging findings were randomly selected for inclusion. Thirty-two Mammography Quality Standards Act-qualified radiologists independently evaluated FFDM followed immediately by FFDM plus UST for suspicious findings and assigned a Breast Imaging Reporting and Data System (BI-RADS) category. The superiority of FFDM plus UST versus FFDM alone for cancer detection (assessed with area under the receiver operating characteristic curve [AUC]), BI-RADS 4 sensitivity, and BI-RADS 3 sensitivity and specificity were evaluated using the two-sided significance level of α = .05. Noninferiority of BI-RADS 4 specificity was evaluated at the one-sided significance level of α = .025 with a -10% margin.
RESULTS: Among 140 women (mean age, 56 years ±10 [SD]; 36 with cancer, 104 without), FFDM plus UST achieved superior performance compared with FFDM alone (AUC, 0.60 [95% CI: 0.51, 0.69] vs 0.54 [95% CI: 0.45, 0.64]; P = .03). For FFDM plus UST versus FFDM alone, BI-RADS 4 mean sensitivity was superior (37% [428 of 1152] vs 30% [343 of 1152]; P = .03) and BI-RADS 4 mean specificity was noninferior (82% [2741 of 3328] vs 88% [2916 of 3328]; P = .004). For FFDM plus UST versus FFDM, no difference in BI-RADS 3 mean sensitivity was observed (40% [461 of 1152] vs 33% [385 of 1152]; P = .08), but BI-RADS 3 mean specificity was superior (75% [2491 of 3328] vs 69% [2299 of 3328]; P = .04).
CONCLUSION: In women with dense breasts, FFDM plus UST improved cancer detection by radiologists versus FFDM alone. Clinical trial registration nos. NCT03257839 and NCT04260620 Published under a CC BY 4.0 license. Supplemental material is available for this article. See also the editorial by Mann in this issue.
引用
- Yamashita MW, Larsen LH, Perez J, et al. Comparison of Mammography and Mammography with Supplemental Whole-Breast US Tomography for Cancer Detection in Patients with Dense Breasts. Radiology. 2024. PMID: 38888480. doi:10.1148/radiol.231680
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。